Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)
Open Access
- 8 June 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 31 (1), 1-10
- https://doi.org/10.1038/leu.2016.160
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Assessment of Minimal Residual Disease in Standard-Risk AMLNew England Journal of Medicine, 2016
- Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaPublished by American Medical Association (AMA) ,2015
- Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformationBlood, 2015
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceNew England Journal of Medicine, 2014
- The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active TetramersCancer Cell, 2014
- DNMT3AMutations in Acute Myeloid LeukemiaNew England Journal of Medicine, 2010
- Acute myeloid leukaemiaThe Lancet, 2006
- Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy.2005
- Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?Proceedings of the National Academy of Sciences of the United States of America, 2003
- The human DDX and DHX gene families of putative RNA helicasesGenomics, 2003